Polypeptide used for prevention and treatment of acute coronary syndrome and anticoagulation antithrombotic therapy and application thereof
A syndrome and antithrombotic technology, applied in the direction of peptides, tripeptides, tetrapeptides, etc., can solve the problems of long oral onset time and difficulty in inhibiting platelet aggregation
Active Publication Date: 2011-11-16
SHAANXI MICOT TECH LTD
View PDF1 Cites 8 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
The commonly used clinical preparations of aspirin and clopidogrel are oral preparations. For ACS patients admitted to the emergency department, clopidogrel takes a long time to take effect when taken orall
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
Login to View More
PUM
Login to View More
Abstract
The invention relates to a polypeptide used for prevention and treatment of acute coronary syndrome and anticoagulation antithrombotic therapy and application thereof. A sequence of the polypeptide disclosed by the invention is P1 Pro-Ser-Hyp-Gly-Asp-TrpP2 Pro-Ser-Hyp-Gly-Asp-Trp-ArgP3 Pro-Ser-Lys-Gly-Asp-TrpP4 Pro-Ser-Val-Gly-Asp-TrpP5 Pro-Ser-Nva-Gly-Asp-Trp-ArgP6 Pro-Ser-Pro-Gly-Asp-TrpP7 Pro-Ser-Thz-Gly-Asp-Trp, the polypeptide is independently used or combined with aspirin, clopidogrel or heparin, is used for inhibiting platelet aggregation and thrombosis and is taken as an effective ingredient for preparing a medicine used for prevention and treatment of acute coronary syndrome, unstable angina and acute myocardial infarction and intervention therapy of anticoagulation antithrombotic therapy. The polypeptide provided by the invention can be combined with a human blood platelet GPIIb-IIIa receptor, and has the capabilities of blocking blood platelet aggregation induced by adenosine diphosphate, arachidonic acid and thrombin and effectively inhibiting coronary thrombosis and femoral thrombosis.
Description
technical field [0001] The invention belongs to the technical field of medicine preparation, and specifically relates to a polypeptide for preventing and treating acute coronary syndrome and anticoagulant and antithrombotic therapy and its application. The polypeptide involved in the present invention is derived from human fibrinogen, can bind to human platelet GPIIb-IIIa receptors, can block platelet aggregation induced by adenosine diphosphate, arachidonic acid and thrombin, and can inhibit arterial thrombosis. For acute coronary syndrome, unstable angina, acute myocardial infarction, anticoagulant and antithrombotic therapy for interventional therapy, etc. Background technique [0002] Acute coronary syndrome (ACS) refers to a group of clinical symptoms caused by acute myocardial ischemia, usually due to coronary atherosclerotic plaque rupture or surface erosion, which induces thrombosis or vasospasm, causing myocardial oxygen supply Severe myocardial ischemic events cau...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More Application Information
Patent Timeline
Login to View More
IPC IPC(8): C07K5/08C07K5/10C07K7/06C07K7/08C07K1/04A61K38/06A61K38/07A61K38/08A61K38/10A61P9/10A61P7/02
Inventor 王冰
Owner SHAANXI MICOT TECH LTD
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com